secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACCENDRA HEALTH INC/VA/ (ACH)
CIK:        0000075252
Form:       8-K
Filed at:   2023-05-05T23:59:59+00:00
Accession:  0000075252-23-000022
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Owens & Minor posts Q1 net loss $(0.32)/share; raises 2023 guidance on Patient Direct strength
--------------------------------------------------------------------------------

- Revenue $2.5B (+4.8% YoY); GAAP net loss $24.4M vs. net income $39.3M in Q1 2022.
- Adjusted EPS $0.05 vs. $0.96 prior year; adjusted operating income $47.7M vs. $104.9M.
- Patient Direct segment drove margin expansion; Products & Healthcare Services saw destocking pressure.
- Raised 2023 guidance: revenue $10.35-10.55B, adjusted EBITDA $480-510M (from $465-490M).
- Generated $158M operating cash flow; paid down $117M debt in Q1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/75252/000007525223000022/0000075252-23-000022-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/75252/000007525223000022/omi-20230505.htm
  HTML page:      https://secwatch.observer/filing/0000075252-23-000022

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer